@misc{10481/66380,
year = {2020},
month = {10},
url = {http://hdl.handle.net/10481/66380},
organization = {Instituto de Salud Carlos III

CP19/00029
CP14/00197
PI19/01533
PI15/00336},
organization = {Spanish Government

RTC-2016-5674-1},
organization = {European Union (EU)},
organization = {Ministerio de Ciencia, Innovación y Universidades 	
FPU19/04450},
organization = {Fundación Científica Asociación Española Contra el Cáncer, Junta Provincial de Jaén (AECC) 	
PRDJA19001BLAY},
publisher = {Mdpi},
keywords = {Triple-negative breast cancer},
keywords = {Personalized medicine},
keywords = {Computational methods},
keywords = {Drug repurposing},
keywords = {Clinical trials},
keywords = {Cancer stem cells},
title = {Drug Repurposing for Triple-Negative Breast Cancer},
doi = {10.3390/jpm10040200},
author = {Ávalos Moreno, Marta and López Tejada, Araceli and Blaya Cánovas, José L. and Cara Lupiáñez, Francisca E. and González González, Adrián and Lorente Acosta, José Antonio and Sánchez Rovira, Pedro and Granados Principal, Sergio},
}